Synapse - Paul Fearn

Search Within

Paul A Fearn

Results (59)

Why can't nomograms be more like Netflix?

Journal Article

Vickers, A. J.; Fearn, P.; Scardino, P. T.; Kattan, M. W.
Urology (2010)

Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable

Journal Article

Potters, L.; Roach, M. 3rd; Davis, B. J.; Stock, R. G.; Ciezki, J. P.; Zelefsky, M. J.; Stone, N. N.; Fearn, P. A.; Yu, C.; Shinohara, K.; more...
International Journal of Radiation Oncology, Biology, Physics (2010)

Fulltext@MSK | Save

Development of a virtual reality coping skills game to prevent post-hospitalization smoking relapse in tobacco dependent cancer patients

Journal Article

Krebs, P.; Burkhalter, J.; Lewis, S.; Hendrickson, T.; Chiu, O.; Fearn, P.; Perchick, W.; Ostroff, J.
Journal of Virtual Worlds Research (2009)

Fulltext@MSK | Save

Human error and privacy breaches in healthcare organizations: Causes and management strategies

Conference Paper

Liginlal, D.; Sim, I.; Khansa, L.; Fearn, P.
Association for Information Systems (AIS) (2009)

Fulltext@MSK | Save

Multicenter Analysis of Effect of High Biologic Effective Dose on Biochemical Failure and Survival Outcomes in Patients With Gleason Score 7-10 Prostate Cancer Treated With Permanent Prostate Brachytherapy

Journal Article

Stone, N. N.; Potters, L.; Davis, B. J.; Ciezki, J. P.; Zelefsky, M. J.; Roach, M.; Shinohara, K.; Fearn, P. A.; Kattan, M. W.; Stock, R. G.
International Journal of Radiation Oncology, Biology, Physics (2009)

Fulltext@MSK | Save

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy

Journal Article

O'brien, M. F.; Cronin, A. M.; Fearn, P. A.; Smith, B.; Stasi, J.; Guillonneau, B.; Scardino, P. T.; Eastham, J. A.; Vickers, A. J.; Lilja, H.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer (Reprinted from The Journal of Urology, vol 173, pg 1562-1566, 2005)

Journal Article

Potters, L.; Morgenstern, C.; Calugaru, E.; Fearn, P.; Jassal, A.; Presser, J.; Mullen, E.
Journal of Urology (2008)

Fulltext@MSK | Save

In reply to Drs. Oton and Oton

Journal Article

Stone, N. N.; Stock, R. G.; Potters, L.; Davis, B. J.; Ciezki, J. P.; Kattan, M. W.; Zelefsky, M. J.; Fearn, P. A.; Roach, M.
International Journal of Radiation Oncology, Biology, Physics (2008)

Fulltext@MSK | Save

Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent

Journal Article

Kattan, M. W.; Cuzick, J.; Fisher, G.; Berney, D. M.; Oliver, T.; Foster, C. S.; Møller, H.; Reuter, V.; Fearn, P.; Eastham, J.; more...
Cancer (2008)

Fulltext@MSK | Save

Local progression among men with conservatively treated localized prostate cancer: Results from the Transatlantic Prostate Group

Journal Article

Eastham, J. A.; Kattan, M. W.; Fearn, P.; Fisher, G.; Berney, D. M.; Oliver, T.; Foster, C. S.; Møller, H.; Reuter, V.; Cuzick, J.; more...
European Urology (2008)

Fulltext@MSK | Save